The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification

Cerebrovascular Diseases

Volumn 8, Issue 4, 1998, Pages 198-203

  Steiner, Thorsten ^a   Bluhmki, Erich ^a   Kaste, Markku ^a   Toni, Danilo ^a   Trouillas, Paul ^a   Von Kummer, Rüdiger ^a   Hacke, Werner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ECASS; rt PA; Stroke; Thrombolysis; Time window

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CEREBROVASCULAR DISORDERS; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; RECOMBINANT PROTEINS; STATISTICS; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0031875596     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000015851     Document Type: Article

References (11)

1. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne M-H: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025.
2. NINDS rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
3. Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, McNeil JJ, Rosen D, Stewart-Wynne EG, Tuck RR, for the Australian Streptokinase (ASK) Trial Group: Streptokinase for acute ischemic stroke with relationship to time of administration. JAMA 1996;25:961-966.
4. Multicentre Acute Stroke Trial-Italy (MAST-1) Group: Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 1995;345:1509-1515.
5. The Multicenter Acute Stroke Trial-Europe Study Group: Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med 1996;335:145-150.
6. Boysen G, Hacke W: European Cooperative Acute Stroke Study (ECASS): Study design and progress report. Eur J Neurol 1995;1:213-219.
7. Tilley BC, Marler J, Geller NL, Lu M, Legler J, Brott T, Lyden P, Grotta J, for the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Trial Group: Use of global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Stroke 1996;27:2136-2142.
8. von Kummer R, Bozzao L, Manelfe C: Early CT Diagnosis of Hemispheric Brain Infarction. Berlin, Springer, 1995.
9. von Kummer R, Meyding-Lamade U, Forsting ML, Rosin L, Ricke K, Hacke W, Sartor K; Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR 1994;15:9-15.
10. Baron JC, von Kummer R, del Zoppo GJ: Treatment of acute ischemic stroke: Challenging the concept of a rigid and universal time window. Stroke 1995;26:2219-2221.
11. Toni D, Fiorelli M, Gentile M, Bastianello S, Sachetti ML, Argentino C, Pozzilli C, Fieschi C: Progressing neurological deficit secondary to acute ischemic stroke: A study on predictability, pathogenesis and prognosis. Arch Neurol 1995;52:670-675.